Potential roles of BMP9 in liver fibrosis

International Journal of Molecular Sciences

Volumn 15, Issue 11, 2014, Pages 20656-20667

  Bi, Jianjun ^a   Ge, Shengfang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Activin receptor like kinase 1 (ALK1); Bone morphogenetic Pprotein 9 (BMP9); Endoglin; Hepcidin; Inhibitor of differentiation 1 (Id1); Liver fibrosis; Snail

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BONE MORPHOGENETIC PROTEIN 9; BONE MORPHOGENETIC PROTEIN RECEPTOR; ENDOGLIN; HEPCIDIN; INHIBITOR OF DIFFERENTIATION 1; MITOGEN ACTIVATED PROTEIN KINASE; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; VIMENTIN;

BONE DEVELOPMENT; CELL DIFFERENTIATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER REGENERATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

GASTROPODA;

ANIMALS; GROWTH DIFFERENTIATION FACTOR 2; HUMANS; LIVER; LIVER CIRRHOSIS; SIGNAL TRANSDUCTION;

EID: 84910136815     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151120656     Document Type: Review

References (72)

1. Ramachandran, P.; Iredale, J.P. Liver fibrosis: A bidirectional model of fibrogenesis and resolution. QJM 2012, 105, 813-817.
2. Mastroianni, C.M.; Lichtner, M.; Mascia, C.; Zuccala, P.; Vullo, V. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection. Int. J. Mol. Sci. 2014, 15, 9184-9208.
3. Mallat, A.; Lotersztajn, S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.Am. J. Physiol. Cell Physiol. 2013, 305, C789-C799.
4. Pinzani, M.; Macias-Barragan, J. Update on the pathophysiology of liver fibrosis. Expert Rev. Gastroenterol. Hepatol. 2010, 4, 459-472.
5. Su, T.H.; Kao, J.H.; Liu, C.J. Molecular mechanism and treatment of viral hepatitis-related liver fibrosis. Int. J. Mol. Sci. 2014, 15, 10578-10604.
6. Xu, R.; Zhang, Z.; Wang, F.S. Liver fibrosis: Mechanismsof immune-mediated liver injury. Cell. Mol. Immunol. 2012, 9, 296-301.
7. Povero, D.; Busletta, C.; Novo, E.; di Bonzo, L.V.; Cannito, S.; Paternostro, C.; Parola, M. Liver fibrosis: A dynamic and potentially reversible process. Histol. Histopathol. 2010, 25, 1075-1091.
8. Gressner, O.A.; Rizk, M.S.; Kovalenko, E.; Weiskirchen, R.; Gressner, A.M. Changing the pathogeneticroadmap of liver fibrosis? Where did it start; where will it go?J. Gastroenterol. Hepatol. 2008, 23, 1024-1035.
9. Lamplot, J.D.; Qin, J.; Nan, G.; Wang, J.; Liu, X.; Yin, L.; Tomal, J.; Li, R.; Shui, W.; Zhang, H., et al. BMP9 signaling in stem cell differentiation and osteogenesis. Am. J. Stem Cells 2013, 2, 1-21.
10. Brown, M.A.; Zhao, Q.; Baker, K.A.; Naik, C.; Chen, C.; Pukac, L.; Singh, M.; Tsareva, T.; Parice, Y.; Mahoney, A., et al. Crystal structure of BMP9 and functional interactions with pro-region and receptors. J. Biol. Chem. 2005, 280, 25111-25118.
11. Ten Dijke, P.; Arthur, H.M. Extracellular control of TGF-β signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 2007, 8, 857-869.
12. Song, J.J.; Celeste, A.J.; Kong, F.M.; Jirtle, R.L.; Rosen, V.; Thies, R.S. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 1995, 136, 4293-4297.
13. Bidart, M.; Ricard, N.; Levet, S.; Samson, M.; Mallet, C.; David, L.; Subileau, M.; Tillet, E.; Feige, J.J.; Bailly, S. BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain. Cell. Mol. Life Sci. 2012, 69, 313-324.
14. Miller, A.F.; Harvey, S.A.; Thies, R.S.; Olson, M.S. Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J. Biol. Chem. 2000, 275, 17937-17945.
15. Truksa, J.; Peng, H.; Lee, P.; Beutler, E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc. Natl. Acad. Sci. USA 2006, 103, 10289-10293.
16. Kang, Q.; Sun, M.H.; Cheng, H.; Peng, Y.; Montag, A.G.; Deyrup, A.T.; Jiang, W.; Luu, H.H.; Luo, J.; Szatkowski, J.P., et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 2004, 11, 1312-1320.
17. Scharpfenecker, M.; van Dinther, M.; Liu, Z.; van Bezooijen, R.L.; Zhao, Q.; Pukac, L.; Lowik, C.W.; TenDijke, P. BMP9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J. Cell Sci. 2007, 120, 964-972.
18. David, L.; Mallet, C.; Keramidas, M.; Lamande, N.; Gasc, J.M.; Dupuis-Girod, S.; Plauchu, H.; Feige, J.J.; Bailly, S. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ. Res. 2008, 102, 914-922.
19. Schnitzler, A.C.; Mellott, T.J.; Lopez-Coviella, I.; Tallini, Y.N.; Kotlikoff, M.I.; Follettie, M.T.; Blusztajn, J.K. BMP9 (bone morphogenetic protein-9) induces NGF as an autocrine/paracrine cholinergic trophic factor in developing basal forebrain neurons. J. Neurosci. 2010, 30, 8221-8228.
20. Chen, C.; Grzegorzewski, K.J.; Barash, S.; Zhao, Q.; Schneider, H.; Wang, Q.; Singh, M.; Pukac, L.; Bell, A.C.; Duan, R., et al. An integrated functional genomics screening program reveals a role for BMP9 in glucose homeostasis. Nat. Biotechnol. 2003, 21, 294-301.
21. David, L.; Mallet, C.; Mazerbourg, S.; Feige, J.J.; Bailly, S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor like kinase 1 (ALK1) in endothelial cells. Blood 2007, 109, 1953-1961.
22. Townson, S.A.; Martinez-Hackert, E.; Greppi, C.; Lowden, P.; Sako, D.; Liu, J.; Ucran, J.A.; Liharska, K.; Underwood, K.W.; Seehra, J., et al. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex. J. Biol. Chem. 2012, 287, 27313-27325.
23. Mueller, T.D.; Nickel, J. Promiscuity and specificity in BMP receptor activation. FEBS Lett. 2012, 586, 1846-1859.
24. Herrera, B.; Dooley, S.; Breitkopf-Heinlein, K. Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases. Int. J. Mol. Sci. 2014,15, 5199-5220.
25. Herrera, B.; van Dinther, M.; ten Dijke, P.; Inman, G.J. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.Cancer Res. 2009,69, 9254-9262.
26. Popov, Y.; Patsenker, E.; Stickel, F.; Zaks, J.; Bhaskar, K.R.; Niedobitek, G.; Kolb, A.; Friess, H.; Schuppan, D. Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J. Hepatol. 2008,48, 453-464.
27. Arndt, S.; Maegdefrau, U.; Dorn, C.; Schardt, K.; Hellerbrand, C.; Bosserhoff, A.K. Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. Gastroenterology 2010,138, 372-382.
28. Xia, Y.; Babitt, J.L.; Sidis, Y.; Chung, R.T.; Lin, H.Y. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 2008,111, 5195-5204.
29. Li, Q.; Gu, X.; Weng, H.; Ghafoory, S.; Liu, Y.; Feng, T.; Dzieran, J.; Li, L.; Ilkavets, I.; Kruithof-de Julio, M., et al. Bone morphogenetic protein-9 induces epithelial to mesenchymal transition in hepatocellular carcinoma cells. Cancer Sci. 2013,104, 398-408.
30. Zilberberg, L.; tenDijke, P.; Sakai, L.Y.; Rifkin, D.B. A rapid and sensitive bioassay to measure bone morphogenetic protein activity. BMC Cell Biol. 2007,8, 41.
31. Wiercinska, E.; Wickert, L.; Denecke, B.; Said, H.M.; Hamzavi, J.; Gressner, A.M.; Thorikay, M.; ten Dijke, P.; Mertens, P.R.; Breitkopf, K., et al. Id1 is a critical mediator in TGF-β-induced transdifferentiation of rat hepatic stellate cells. Hepatology 2006,43, 1032-1041.
32. Panchenko, M.P.; Williams, M.C.; Brody, J.S.; Yu, Q. Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels. Am. J. Physiol. 1996,270, L547-L558.
33. Gonzalez-Nunez, M.; Munoz-Felix, J.M.; Lopez-Novoa, J.M. The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?Biochim. Biophys. Acta 2013, 1832, 1492-1510.
34. Upton, P.D.; Davies, R.J.; Trembath, R.C.; Morrell, N.W. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J. Biol. Chem. 2009,284, 15794-15804.
35. Star, G.P.; Giovinazzo, M.; Langleben, D. Bone morphogenic protein-9 stimulates endothelin-1 release from human pulmonary microvascular endothelial cells: A potential mechanism for elevated ET-1 levels in pulmonary arterial hypertension. Microvasc. Res. 2010,80, 349-354.
36. Xu, D.J.; Zhao, Y.Z.; Wang, J.; He, J.W.; Weng, Y.G.; Luo, J.Y. Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells BMB Rep. 2012, 45, 247-252.
37. Zhao, Y.F.; Xu, J.; Wang, W.J.; Wang, J.; He, J.W.; Li, L.; Dong, Q.; Xiao, Y.; Duan, X.L.; Yang, X., et al. Activation of JNKs is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells. BMB Rep. 2013,46, 422-427.
38. Zhao, Y.; Song, T.; Wang, W.; Wang, J.; He, J.; Wu, N.; Tang, M.; He, B.; Luo, J. P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One 2012,7, e43383.
39. Munoz-Felix, J.M.; Gonzalez-Nunez, M.; Lopez-Novoa, J.M. ALK1-Smad1/5 signaling pathway in fibrosis development: Friend or foe?Cytokine Growth Factor Rev. 2013,24, 523-537.
40. Shen, H.; Fan, J.; Burczynski, F.; Minuk, G.Y.; Cattini, P.; Gong, Y. Increased Smad1 expression and transcriptional activity enhances trans-differentiation of hepatic stellate cells. J. Cell. Physiol. 2007, 212, 764-770.
41. Pannu, J.; Nakerakanti, S.; Smith, E.; ten Dijke, P.; Trojanowska, M. Transforming growth factor-β receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J. Biol. Chem. 2007,282, 10405-10413.
42. Beger, B.; Robertson, K.; Evans, A.; Grant, A.; Berg, J. Expression of endoglin and the activin receptor-like kinase 1 in skin suggests a role for these receptors in normal skin function and skin tumorigenesis. Br. J. Dermatol. 2006,154, 379-382.
43. Li, L.; Zhao, X.Y.; Wang, B.E. Down-regulation of transforming growth factor β1/activin receptor-like kinase 1pathway gene expression by herbal compound 861 is related to deactivation of LX-2 cells. World J. Gastroenterol. 2008,14, 2894-2899.
44. Wang, L.; Wang, B.E.; Wang, J.; Xiao, P.G.; Tan, X.H. Herbal compound 861 regulates mRNA expression of collagen synthesis-and degradation-related genes in human hepatic stellate cells. World J.Gastroenterol. 2008,14, 1790-1794.
45. Kaimori, A.; Potter, J.; Kaimori, J.Y.; Wang, C.; Mezey, E.; Koteish, A. Transforming growth factor-β1 induces anepithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem. 2007,282, 22089-22101.
46. Bernabeu, C.; Lopez-Novoa, J.M.; Quintanilla, M. The emerging role of TGF-β superfamily coreceptors in cancer. Biochim. Biophys. Acta 2009,1792, 954-973.
47. Meurer, S.K.; Tihaa, L.; Borkham-Kamphorst, E.; Weiskirchen, R. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. Cell Signal. 2011,23,683-699.
48. Guerrero-Esteo, M.; Sanchez-Elsner, T.; Letamendia, A.; Bernabeu, C. Extracellular and cytoplasmic domains of endoglin interactwith the transforming growth factor-β receptors I and II. J. Biol. Chem. 2002,277, 29197-29209.
49. Koleva, R.I.; Conley, B.A.; Romero, D.; Riley, K.S.; Marto, J.A.; Lux, A.; Vary, C.P. Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-β receptors. J. Biol. Chem. 2006,281, 25110-25123.
50. Finnson, K.W.; Philip, A. Endoglin in liver fibrosis. J. Cell Commun. Signal. 2012, 6, 1-4.
51. Finnson, K.W.; Parker, W.L.; Chi, Y.; Hoemann, C.D.; Goldring, M.B.; Antoniou, J.; Philip, A. Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthritis Cartilage 2010, 18, 1518-1527.
52. Morris, E.; Chrobak, I.; Bujor, A.; Hant, F.; Mummery, C.; ten Dijke, P.; Trojanowska, M. Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts. J. Cell. Physiol. 2011,226, 3340-3348.
53. Scherner, O.; Meurer, S.K.; Tihaa, L.; Gressner, A.M.; Weiskirchen, R. Endoglin differentially modulates antagonistic transforming growth factor-β1 and BMP-7 signaling. J. Biol. Chem. 2007, 282, 13934-13943.
54. Clemente, M.; Nunez, O.; Lorente, R.; Rincon, D.; Matilla, A.; Salcedo, M.; Catalina, M.V.; Ripoll, C.; Iacono, O.L.; Banares, R., et al. Increased intrahepatic and circulating levels of endoglin, a TGF-β1 co-receptor, in patients with chronic hepatitis C virus infection: Relationship to histological and serum markers of hepatic fibrosis. J. Viral Hepat. 2006,13, 625-632.
55. Preativatanyou, K.; Honsawek, S.; Chongsrisawat, V.; Vejchapipat, P.; Theamboonlers, A.; Poovorawan, Y. Correlation of circulating endoglin with clinical outcome in biliary atresia. Eur. J. Pediatr. Surg. 2010,20, 237-241.
56. Meurer, S.K.; Alsamman, M.; Sahin, H.; Wasmuth, H.E.; Kisseleva, T.; Brenner, D.A.; Trautwein, C.; Weiskirchen, R.; Scholten, D. Overexpression of endoglin modulates TGF-β1-signalling pathways in a novel immortalized mouse hepatic stellate cell line. PLoS One 2013, 8, e56116.
57. Herrera, B.; Garcia-Alvaro, M.; Cruz, S.; Walsh, P.; Fernandez, M.; Roncero, C.; Fabregat, I.; Sanchez, A.; Inman, G.J. BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells. PLoS One 2013,8, e69535.
58. Li, M.X.; Liu, B.C. Epithelial to mesenchymal transition in the progression of tubulointerstitial fibrosis. Chin. Med. J. 2007,120, 1925-1930.
59. Ding, B.S.; Cao, Z.; Lis, R.; Nolan, D.J.; Guo, P.; Simons, M.; Penfold, M.E.; Shido, K.; Rabbany, S.Y.; Rafii, S. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature 2014,505, 97-102.
60. Matsuda, Y.; Yamagiwa, S.; Takamura, M.; Honda, Y.; Ishimoto, Y.; Ichida, T.; Aoyagi, Y. Overexpressed Id-1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16. Cancer 2005,104, 1037-1044.
61. Vincent, K.J.; Jones, E.; Arthur, M.J.; Smart, D.E.; Trim, J.; Wright, M.C.; Mann, D.A. Regulation of E-box DNA binding during in vivoand in vitroactivation of rat and human hepatic stellate cells. Gut 2001,49, 713-719.
62. Abu Rajab, M.; Guerin, L.; Lee, P.; Brown, K.E. Iron overload secondary to cirrhosis: A mimic of hereditary haemochromatosis? Histopathology 2014, 65, 561-569.
63. Costa-Matos, L.; Batista, P.; Monteiro, N.; Simoes, M.; Egas, C.; Pereira, J.; Pinho, H.; Santos, N.; Ribeiro, J.; Cipriano, M.A., et al. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls. Eur. J. Gastroenterol. Hepatol. 2012,24, 1158-1165.
64. Horl, W.H.; Schmidt, A. Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C. Nephrol.Dial. Transplant. 2014,29, 1141-1144.
65. Fujita, N.; Horiike, S.; Sugimoto, R.; Tanaka, H.; Iwasa, M.; Kobayashi, Y.; Hasegawa, K.; Ma, N.; Kawanishi, S.; Adachi, Y., et al. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radic. Biol. Med. 2007,42, 353-362.
66. Zhao, J.Y.; Li, Y.W.; Li, L. The role of ironand hepcidin in hepatic fibrosis. Prog. Physiol. 2010,41, 183-188.
67. Nagashima, M.; Kudo, M.; Chung, H.; Ishikawa, E.; Hagiwara, S.; Nakatani, T.; Dote, K. Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol. Res. 2006,36,288-293.
68. Fujita, N.; Sugimoto, R.; Takeo, M.; Urawa, N.; Mifuji, R.; Tanaka, H.; Kobayashi, Y.; Iwasa, M.; Watanabe, S.; Adachi, Y.; et al. Hepcidin expression in the liver: Relatively low level in patients with chronic hepatitis C. Mol. Med. 2007,13, 97-104.
69. Tanno, T.; Bhanu, N.V.; Oneal, P.A.; Goh, S.H.; Staker, P.; Lee, Y.T.; Moroney, J.W.; Reed, C.H.; Luban, N.L.; Wang, R.H., et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med. 2007, 13, 1096-1101.
70. Sebastiani, G.; Gkouvatsos, K.; Maffettone, C.; Busatto, G.; Guido, M.; Pantopoulos,K. Accelerated CCl4-induced liver fibrosis in Hjv−/−mice, associated with an oxidative burst and precocious profibrogenic gene expression. PLoS One 2011,6, e25138.
71. Gordillo-Bastidas, D.; Oceguera-Contreras, E.; Salazar-Montes, A.; Gonzalez-Cuevas, J.; Hernandez-Ortega, L.D.; Armendariz-Borunda, J. Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine. World J. Gastroenterol. 2013,19, 9020-9033.
72. Bi, W.R.; Jin, C.X.; Xu, G.T.; Yang, C.Q. Bone morphogenetic protein-7 regulates Snail signaling in carbon tetrachloride-induced fibrosis in the rat liver. Exp. Ther. Med. 2012,4, 1022-1026.